期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
MicroRNA-27a-mediated repression of cysteine-rich secretory protein 2 translation in asthenoteratozoospermic patients 被引量:5
1
作者 Jun-Hao Zhou Qi-Zhao Zhou +9 位作者 Jian-Kun Yang Xiao-Ming Lyu Jun Bian Wen-Bin Guo Zi-Jian Chen Ming Xia Hui Xia Tao Qi Xin Li Cun-Dong Liu 《Asian Journal of Andrology》 SCIE CAS CSCD 2017年第5期591-595,共5页
Cysteine-rich secretory protein 2 (CRISP2) is an important protein in spermatozoa that plays roles in modulating sperm flagellar motility, the acrosome reaction, and gamete fusion. Spermatozoa lacking CRISP2 exhibit... Cysteine-rich secretory protein 2 (CRISP2) is an important protein in spermatozoa that plays roles in modulating sperm flagellar motility, the acrosome reaction, and gamete fusion. Spermatozoa lacking CRISP2 exhibit low sperm motility and abnormal morphology. However, the molecular mechanisms underlying the reduction of CRISP2 in asthenoteratozoospermia (ATZ) remain unknown. In this study, low expression of CRISP2 protein rather than its mRNA was observed in the ejaculated spermatozoa from ATZ patients as compared with normozoospermic males. Subsequently, bioinformatic prediction, luciferase reporter assays, and microRNA-27a (miR-27a) transfection experiments revealed that miR-27a specifically targets CRISP2 by binding to its 3' untranslated region (3'-UTR), suppressing CRISP2 expression posttranscriptionally. Further evidence was provided by the clinical observation of high miR-27a expression in ejaculated spermatozoa from ATZ patients and a negative correlation between miR-27a expression and CRISP2 protein expression. Finally, a retrospective follow-up study supported that both high miR-27a expression and low CRISP2 protein expression were associated with low progressive sperm motility, abnormal morphology, and infertility. This study demonstrates a novel mechanism responsible for reduced CRISP2 expression in ATZ, which may offer a potential therapeutic target for treating male infertility, or for male contraception. 展开更多
关键词 asthenoteratozoospermia cysteine-rich secretory protein 2 male infertility microRNA-27a
原文传递
血清CRISPLD2水平对脓毒症患者的诊断及预后评估价值 被引量:8
2
作者 王来 杨秀芬 +1 位作者 张书利 朱孟莎 《中华危重病急救医学》 CAS CSCD 北大核心 2017年第8期694-699,共6页
目的 探讨血清半胱氨酸富集分泌蛋白含LCCL结构域2(CRISPLD2)水平对脓毒症的诊断及预后预测价值.方法 回顾性分析2014年12月至2016年12月入住河北医科大学第一医院重症加强治疗病房(ICU)成人脓毒症患者的临床资料,根据其病情严重程... 目的 探讨血清半胱氨酸富集分泌蛋白含LCCL结构域2(CRISPLD2)水平对脓毒症的诊断及预后预测价值.方法 回顾性分析2014年12月至2016年12月入住河北医科大学第一医院重症加强治疗病房(ICU)成人脓毒症患者的临床资料,根据其病情严重程度分为脓毒症组、严重脓毒症组、脓毒性休克组;同时以100例健康体检者作为健康对照组.收集研究对象入院24 h内血清CRISPLD2、降钙素原(PCT)、C-反应蛋白(CRP)、急性生理学与慢性健康状况评分系统Ⅱ(APACHEⅡ)和序贯器官衰竭评分(SOFA),以及28 d预后;分析脓毒症患者CRISPLD2与PCT、CRP、APACHEⅡ和SOFA评分的相关性;用受试者工作特征曲线(ROC)评估CRISPLD2对脓毒症诊断及预后的预测价值.结果 共入选115例脓毒症患者,其中脓毒症52例,严重脓毒症48例,脓毒性休克15例;28 d死亡29例,病死率为25.2%.脓毒症患者CRISPLD2水平与健康对照组差异无统计学意义(mg/L:204.1±74.5比211.3±12.0,P〉0.05);但脓毒性休克组CRISPLD2水平明显低于脓毒症组和严重脓毒症组(mg/L:139.0±55.0比240.2±89.6、233.0±8.9,均P〈0.05).脓毒症患者PCT、CRP、APACHEⅡ评分、SOFA评分均明显高于健康对照组,且随病情程度加重呈递增趋势.脓毒症死亡者CRISPLD2水平与存活者相比差异无统计学意义,PCT、CRP水平则明显升高.脓毒症患者血清CRISPLD2水平与PCT、CRP、APACHEⅡ评分、SOFA评分均呈负相关(r值分别为-0.089、-0.431、-0.115、-0.201,均P〈0.05).ROC曲线分析显示,CRISPLD2、PCT、CRP诊断脓毒症的ROC曲线下面积(AUC)和95%可信区间(95%CI)分别为0.907(0.871-0.944)、0.922(0.886-0.958)、0.916(0.878-0.954),均P=0.000;当CRISPLD2截断值〉216.0 mg/L时诊断脓毒症的敏感度为96.7%,特异度为92.6%,介于PCT与CPR之间.CRISPLD2评估预后的AUC明显低于PCT〔0.617(0.507-0.727)比0.786(0.668-0.903),P〈0.01〕;当CRISPLD2截断值为103.5 mg/L时,敏感度为100%,但特异度为25.6%.结论 CRISPLD2可作为诊断脓毒症的潜在生物标志物之一,但不能预测脓毒症患者的预后. 展开更多
关键词 脓毒症 半胱氨酸富集分泌蛋白含lccl结构域2 C-反应蛋白 降钙素原 诊断 预后
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部